TNF and neoplasm: In malignant diseases, PD-1 ligands become upregulated on leukocytes in the tumor microenvironment by various pro-inflammatory cytokines, e.g. interferon γ, interleukin 10, and tumor necrosis factor α, produced by tumor cells and other leukocytes such as T cells[3, 29–31].